U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta - Reuters

U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta  Reuters

The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co's lung cancer drug Alimta.